TOWER CANCER RESEARCH FOUNDATION

EIN: 954596354 501(c)(3) Medical Research

BEVERLY HILLS, CA

Total Revenue
$3,146,877
Total Expenses
$3,636,819
Total Assets
$3,237,640
Net Assets
$1,205,714
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1996
Legal Domicile
CA
Principal Officer
MATTHEW ZARCUFSKY CFRE
Phone
3102998470
Tax Period
2024-01-01 to 2024-12-31

TOWER CANCER RESEARCH FOUNDATION, founded in 1996, is a community nonprofit in the Medical Research sector that reported $3.1M in total revenue in fiscal year 2024. Revenue surged 24% from the prior year, signaling strong growth momentum. Expenses of $3.6M exceeded revenue, resulting in a 16% operating deficit.

Mission

THROUGH LOCAL INVESTMENTS, WE ADVANCE GROUNDBREAKING CANCER RESEARCH AND PROFOUNDLY SUPPORT PEOPLE AFFECTED BY THE DISEASE TO CREATE OUTSIZED IMPACT IN SOUTHERN CALIFORNIA AND BEYOND.

Program Service Accomplishments

Program 1
Expenses: $2,508,236

IN 2023, TOWER FUNDED FOUR NEW CAREER DEVELOPMENT RESEARCH GRANTS FOR FOUR PROMISING YOUNG PHYSICIAN SCIENTISTS LOCATED AT UCLA, UCI AND UCSD. RESEARCH AREAS FOCUS ON INNOVATIVE THERAPIES SUCH AS...

Read more

IN 2023, TOWER FUNDED FOUR NEW CAREER DEVELOPMENT RESEARCH GRANTS FOR FOUR PROMISING YOUNG PHYSICIAN SCIENTISTS LOCATED AT UCLA, UCI AND UCSD. RESEARCH AREAS FOCUS ON INNOVATIVE THERAPIES SUCH AS: THE USE OF PH TO TARGET GLIOBLASTOMA CELLS IN HOPES TO IMPROVE TREATMENT FOR THIS DEADLY DISEASE; USING A MODEL OF SKIN CANCER, A NEW TOOL TO TRACK CANCER CELLS IN THEIR NATURAL HABITAT TO FIND HOW LYMPHATIC VESSELS SHIELD CANCER CELLS AND AID THEIR SPREAD TO OTHER PARTS OF THE BODY; TARGETING LIVER-METASTATIC PANCREATIC CANCER BY IDENTIFYING WEAKNESSES THAT CAN BE EXPLOITED TO SLOW THE GROWTH OF TUMORS IN THE LIVER OR POSSIBLY PREVENT THE ESTABLISHMENT OF METASTASIS FROM HAPPENING IN PANCREATIC CANCER; STEM CELL REPROGRAMMING OF ANTI-TUMOR T CELLS TO MAKE TIL THERAPY A MORE EFFECTIVE TREATMENT. IN ADDITION, TOWER CONTINUED FUNDING MUL-TI-YEAR SENIOR INVESTIGATOR GRANTS. TOTAL SCIENTIFIC GRANT EXPENDITURES IN 2023 TOPPED $700,000. INVESTING IN NOVEL IDEAS OF YOUNG INVESTIGATORS AND EXPERIENCED SENIOR INVESTIGATORS ALLOWS US TO LEVERAGE OUR DONOR DOLLARS TO HAVE MAXIMUM IMPACT. IN 2023 ALONE, TCRF RESEARCHERS REPORTED NEARLY $3M IN FOLLOW-ON FUNDING, DOZENS OF GRANTS, PUBLICATIONS ACADEMIC AWARDS, TWO CLINICAL TRIALS, AND SO MUCH MORE.OUR CLINICALLY-GROUNDED SURVIVORSHIP SUPPORT PROGRAMS, HOSTED BY MAGNOLIA HOUSE, ALIGN WITH THE CHALLENG-ES FACED BY PATIENTS, SURVIVORS, AND THE WHOLE CANCER COMMUNITY. WE PROVIDE INTEGRATIVE HEALTH AND WELL-NESS SUPPORT AND EDUCATION, THROUGH FREE FITNESS, THERAPEUTIC, AND HOLISTIC CLASSES, THAT EMPOWERPEOPLE TO DEVELOP A PHYSICAL AND EMOTIONAL TOOLKIT TO MEET THE CHALLENGES OF CANCER FROM DIAGNOSIS TO SURVIVORSHIP. IN 2023, TOWER INVESTED OVER $500,000 IN SURVIVORSHIP PROGRAMS. IN 2013, MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM OFFERED 20 CLASSES AND HAD 500 VISITS IN THE FIRST YEAR. IN 2023, MAGNOLIA HOUSE OFFERED OVER 1500 CLASSES/SERVICES AND RECEIVED OVER 20,000 PARTICIPANT VISITS. IN RESPONSE TO COVID19, WE CONTINUED OFFERING CLASSES ONLINE VIA ZOOM WHICH HAS EXPANDED THE DEMOGRAPHICS IN WHICH WE SERVICE AND ENABLED US TO INCREASE OUR CLASS CAPACITIES. WE ADDED OUTDOOR PROGRAMMING AT LOCAL PARKS WHICH HAVE BEEN WELL RECEIVED. EVEN WITH AN INCREASE IN CLASS CAPACITIES, MANY OF OUR CLASSES HAD A WAIT LIST WHICH HIGHLIGHTS BOTH THE QUALITY IN THE PROGRAMS WE OFFER AND THE VOID THAT EXISTS, ESPECIALLY WITH THE ISO-LATION MANY CANCER PATIENTS EXPERIENCE. PARTICIPANTS VIEW MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM AS A LIFELINE THAT PROVIDES NOT ONLY ENHANCED QUALITY OF LIFE BUT A COMMUNITY OF FRIENDSHIP, ENCOURAGEMENT, AND COMFORT AS WELL. ONE EXAMPLE THAT REFLECTS THE IMPACT OF MAGNOLIA HOUSE, IS THE SURVIVOR 2 THRIVER PEER TO PEER FUNDRAISING CAMPAIGN WE LAUNCHED IN THE SUMMER OF 2023. OUR GOAL WAS TO RAISE $5,000. MAGNOLIA HOUSE PARTICIPANTS RAISED $30,000 THROUGH THIS CAMPAIGN, HIGHLIGHTING THE DEPTH OF COMMUNITY AND IMPACT OF THE MAGNOLIA HOUSE PROGRAM.TOWER'S COMMUNITY PARTNERSHIP GRANT REVIEW COMMITTEE IS COMPOSED OF EXPERT VOLUNTEERS WHO REVIEW APPLICATIONS IN DEPTH AND THEN MEET TO DISCUSS GRANT APPLICATIONS FROM CANCER SUPPORT ORGANIZATIONS ACROSS SOUTHERN CALIFORNIA. IN 2023, WE FUNDED $200,000 IN COMMUNITY PARTNER GRANTS AND CONTINUED TO REFINE OUR REVIEW PROCESS WITH A NEW GRANT MANAGEMENT SYSTEM, NEW AND EXPERIENCED PEER GRANT REVIEWERS, AND A NEEDS ASSESSMENT TO REFLECT A MORE TARGETED FOCUS ON FUNDING ORGANIZATIONS THAT SUPPORT UNDERSERVED AND UNDER RESOURCED COMMUNITIES ALLOWING US TO EXTEND OUR SUPPORT TO THOSE MOST IN NEED OF CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $3,653,482
Program Service Revenue $0
Investment Income $49,288
Other Revenue $-555,893
TOTAL REVENUE $3,146,877

Expense Breakdown

Grants Paid $889,920
Salaries & Benefits $1,377,520
Fundraising Expenses $738,666
Program Expenses $2,508,236
Other Expenses $1,369,379
TOTAL EXPENSES $3,636,819

Year-over-Year Comparison

2024 2023 Change
Revenue $3,146,877 $2,539,108 +0.2%
Expenses $3,636,819 $3,174,666 +0.1%
Net Income $-489,942 $-635,558 -0.2%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
23
Independent Members
23
Employees
14
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
7
$304,637
Total Directors
25
$304,637
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
NANCY ROSENFELT CHAIRMAN OF THE BOARD 2.00
Officer Director
$0 $0 $0
LARRY ROSENSTEIN VICE CHAIR 2.00
Officer Director
$0 $0 $0
DONNA ROSEN PAST CHAIRMAN OF THE BOARD 2.00
Officer Director
$0 $0 $0
NANCY MISHKIN PAST CHAIRMAN OF THE BOARD 2.00
Director
$0 $0 $0
DAVID SPINGARN TREASURER 2.00
Officer Director
$0 $0 $0
JEANNE SCHNITZER MARKS SECRETARY 2.00
Officer Director
$0 $0 $0
KELLY PRATHER MAGNOLIA COUNCIL PRESIDENT 2.00
Director
$0 $0 $0
JONATHAN LAYNE DEVELOPMENT COMMITTEE CHAI 2.00
Director
$0 $0 $0
SHELLEY WARSAVSKY DIRECTOR 2.00
Director
$0 $0 $0
ELIZABETH DRUCKER DIRECTOR 2.00
Director
$0 $0 $0
LINDA LEVENSON DELSACK DIRECTOR 2.00
Director
$0 $0 $0
BETTY HAAGEN DIRECTOR 2.00
Director
$0 $0 $0
RANDY KATZ DIRECTOR 2.00
Director
$0 $0 $0
BETH GOREN DIRECTOR 2.00
Director
$0 $0 $0
SUSAN KREVOY PHD DIRECTOR 2.00
Director
$0 $0 $0
FRANKIE SHOLEM DIRECTOR 2.00
Director
$0 $0 $0
BARRY ROSENBLOOM MD DIRECTOR 2.00
Director
$0 $0 $0
JOHN CARPTEN PHD DIRECTOR 2.00
Director
$0 $0 $0
GEORGE RADDA DIRECTOR 2.00
Director
$0 $0 $0
HOORA SADLER DIRECTOR 2.00
Director
$0 $0 $0
JULIE SHAMES DIRECTOR 2.00
Director
$0 $0 $0
KATHY SCOTT DIRECTOR 2.00
Director
$0 $0 $0
PEGGY MILES DIRECTOR 2.00
Director
$0 $0 $0
CHRISTOPHER CLINTON CONWAY EXECUTIVE DIRECTOR 40.00
Officer Director
$280,777 $14,810 $295,587
LINDA DAVID EXECUTIVE DIRECTOR (THRU 1/5) 40.00
Officer Director
$9,050 $0 $9,050
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $3,146,877 $3,636,819 $3,237,640 $-489,942
2023 $2,539,108 $3,174,666 $3,927,785 $-635,558
2022 $2,865,725 $3,160,741 $4,621,629 $-295,016
2021 $2,998,998 $3,480,662 $3,869,425 $-481,664
2020 $2,672,021 $2,863,801 $3,952,393 $-191,780
2019 $3,739,380 $2,598,491 $3,940,038 $1,140,889
2018 $3,418,112 $3,668,871 $3,316,830 $-250,759
Explore More Nonprofits
Top 100 Nonprofits in California Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare TOWER CANCER RESEARCH FOUNDATION with other nonprofits in California and across the country.